PapersFlow Research Brief
T-cell and Retrovirus Studies
Research Guide
What is T-cell and Retrovirus Studies?
T-cell and Retrovirus Studies is a research field examining the epidemiology, pathogenesis, clinical manifestations, treatment, and prevention of Human T-cell Leukemia Virus Type 1 (HTLV-1) infection, including viral transmission, proviral load, cellular transformation, immunotherapy, and the role of viral oncogenes in leukemia and lymphoma development.
This field encompasses 60,438 published works on HTLV-1 and related T-cell retroviruses. Key discoveries include the isolation of a T-lymphotropic retrovirus from a patient at risk for AIDS, distinct from previous HTLV isolates (Barré‐Sinoussi et al., 1983). Additional findings involve type C retrovirus particles from lymphocytes of a patient with cutaneous T-cell lymphoma (Poiesz et al., 1980).
Topic Hierarchy
Research Sub-Topics
HTLV-1 Proviral Load and Disease Progression
This sub-topic studies the correlation between HTLV-1 proviral load in peripheral blood and progression to adult T-cell leukemia/lymphoma or HAM/TSP. Researchers develop qPCR assays and longitudinal cohorts to establish prognostic thresholds.
HTLV-1 Transmission Routes and Epidemiology
This sub-topic examines mother-to-child transmission, sexual transmission, and blood transfusion risks for HTLV-1, alongside global prevalence patterns. Researchers model transmission dynamics and evaluate screening programs.
HTLV-1 Tax Oncoprotein in Cellular Transformation
This sub-topic investigates the role of the viral Tax protein in disrupting cell cycle regulation, NF-κB activation, and apoptosis evasion leading to leukemogenesis. Researchers use cell lines and animal models to dissect molecular pathways.
HAM/TSP Pathogenesis and Neuroinflammation
This sub-topic covers the immune-mediated spinal cord damage in HTLV-1-associated myelopathy/tropical spastic paraparesis, focusing on T-cell infiltration and cytokine profiles. Researchers analyze CSF biomarkers and neuropathology.
Immunotherapy for HTLV-1 Associated Leukemia
This sub-topic explores adoptive T-cell therapies, checkpoint inhibitors, and viral antigen-targeted vaccines against adult T-cell leukemia/lymphoma. Researchers conduct clinical trials assessing response rates and immune reconstitution.
Why It Matters
T-cell and Retrovirus Studies has advanced understanding of HTLV-1's role in diseases like adult T-cell leukemia/lymphoma and tropical spastic paraparesis. Barré‐Sinoussi et al. (1983) isolated a retrovirus from a patient with pre-AIDS symptoms, enabling detection of viruses linked to immune deficiencies affecting millions. Poiesz et al. (1980) detected type C retrovirus particles in HUT 102 and CTCL-3 cell lines from a cutaneous T-cell lymphoma patient, supporting research into viral oncogenesis. Gessain et al. (1985) found antibodies to HTLV-1 in tropical spastic paraparesis patients, connecting the virus to neurological disorders. Parkin (2006) estimated the global cancer burden from infections, highlighting HTLV-1's contribution to leukemia cases worldwide.
Reading Guide
Where to Start
'Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)' by Barré‐Sinoussi et al. (1983), as it provides the foundational isolation of a novel HTLV-related retrovirus, introducing core concepts of T-cell tropism and clinical relevance.
Key Papers Explained
Barré‐Sinoussi et al. (1983) first isolated a distinct T-lymphotropic retrovirus from a pre-AIDS patient, building the HTLV family framework. Poiesz et al. (1980) extended this by detecting type C retroviruses in cutaneous T-cell lymphoma lymphocytes, linking viruses to malignancy. Gallo et al. (1984) and Popovič et al. (1984) advanced detection of cytopathic HTLV-III from AIDS patients, enabling continuous production and epidemiological studies. Gessain et al. (1985) connected HTLV-1 seropositivity to tropical spastic paraparesis, expanding disease associations.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Studies emphasize proviral load measurement, immunotherapy trials, and oncogene roles in leukemia, as no recent preprints or news are available.
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Isolation of a T-Lymphotropic Retrovirus from a Patient at Ris... | 1983 | Science | 6.8K | ✕ |
| 2 | Detection and isolation of type C retrovirus particles from fr... | 1980 | Proceedings of the Nat... | 5.0K | ✓ |
| 3 | The Use of Molecular Profiling to Predict Survival after Chemo... | 2002 | New England Journal of... | 3.8K | ✓ |
| 4 | Frequent Detection and Isolation of Cytopathic Retroviruses (H... | 1984 | Science | 3.6K | ✕ |
| 5 | Detection, Isolation, and Continuous Production of Cytopathic ... | 1984 | Science | 3.5K | ✕ |
| 6 | The CD4 (T4) antigen is an essential component of the receptor... | 1984 | Nature | 3.5K | ✓ |
| 7 | The global health burden of infection‐associated cancers in th... | 2006 | International Journal ... | 2.9K | ✓ |
| 8 | ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WI... | 1985 | The Lancet | 2.8K | ✕ |
| 9 | Human chronic myelogenous leukemia cell-line with positive Phi... | 1975 | Blood | 2.8K | ✕ |
| 10 | Selective in Vitro Growth of T Lymphocytes from Normal Human B... | 1976 | Science | 2.5K | ✕ |
Frequently Asked Questions
What retrovirus was isolated from a patient at risk for AIDS?
Barré‐Sinoussi et al. (1983) isolated a retrovirus belonging to the HTLV family from a Caucasian patient with pre-AIDS signs and symptoms. This virus differed from prior HTLV isolates. The isolation appeared in 'Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)'.
How were type C retrovirus particles detected in T-cell lymphoma?
Poiesz et al. (1980) found type C retrovirus particles in HUT 102 and CTCL-3 T-cell lymphoblastoid cell lines and fresh peripheral blood lymphocytes from a cutaneous T-cell lymphoma patient. These cell lines produced the viruses continuously. The work is detailed in 'Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma'.
What is the connection between HTLV-1 and tropical spastic paraparesis?
Gessain et al. (1985) detected antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. This linked HTLV-1 to the neurological condition. The findings are reported in 'ANTIBODIES TO HUMAN T-LYMPHOTROPIC VIRUS TYPE-I IN PATIENTS WITH TROPICAL SPASTIC PARAPARESIS'.
How was continuous production of HTLV-III achieved from AIDS patients?
Popovič et al. (1984) developed a cell system using specific clones from a permissive human neoplastic T-cell line for reproducible detection and continuous production of cytopathic retroviruses (HTLV-III) from AIDS and pre-AIDS patients. This enabled reliable virus isolation. The method is described in 'Detection, Isolation, and Continuous Production of Cytopathic Retroviruses (HTLV-III) from Patients with AIDS and Pre-AIDS'.
What role does CD4 play in AIDS retrovirus infection?
Dalgleish et al. (1984) showed that the CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. This finding clarified viral entry mechanisms into T-cells. The study appeared in 'The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus'.
Open Research Questions
- ? How does proviral load correlate with progression to HTLV-1-associated myelopathy or leukemia?
- ? What mechanisms drive cellular transformation by HTLV-1 viral oncogenes in lymphoma development?
- ? Which immunotherapy approaches effectively reduce HTLV-1 proviral load in infected patients?
- ? How do transmission routes influence HTLV-1 epidemiology in different global regions?
- ? What factors determine the clinical manifestations of HTLV-1 infection across populations?
Recent Trends
The field maintains 60,438 works with no specified 5-year growth rate.
Seminal papers from 1975-2006, such as Barré‐Sinoussi et al. (1983, 6847 citations) and Poiesz et al. (1980, 5043 citations), dominate citations.
No recent preprints or news coverage in the last 12 months indicates steady focus on established HTLV-1 mechanisms.
Research T-cell and Retrovirus Studies with AI
PapersFlow provides specialized AI tools for Immunology and Microbiology researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching T-cell and Retrovirus Studies with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Immunology and Microbiology researchers